Entero Healthcare Solutions Ltd
NSE:ENTERO
Relative Value
There is not enough data to reliably calculate the relative value of ENTERO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ENTERO Competitors Multiples
Entero Healthcare Solutions Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
E
|
Entero Healthcare Solutions Ltd
NSE:ENTERO
|
50.3B INR | 0 | 0 | 0 | 0 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
113.7B USD | 0.3 | 28.2 | 19.8 | 22.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.7B USD | 0.2 | 42.2 | 14.8 | 18.8 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.7B USD | 0.2 | 42.2 | 14.8 | 18.7 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.4B USD | 0.2 | 30.7 | 14.8 | 19.3 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35B AUD | 5.8 | 66 | 49.8 | 49.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 0.7 | 24.2 | 11.5 | 16.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.8B CNY | 1.5 | 17.3 | 13.3 | 13.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.3B HKD | 0.1 | 8.6 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |